SCHEMBL17437404

SCHEMBL17437404

CCCn1c(-n2ncnc2N)nc2cnccc21

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ RPS6KA5 O75582 12/20 0.47
▸ POLB P06746 1/20 0.41
▸ DYRK1A Q13627 2/20 0.40
▸ RPS6KB1 P23443 1/20 0.40
▸ CDK2 P24941 1/20 0.40
▸ ROCK1 Q13464 1/20 0.40
▸ RPS6KA1 Q15418 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ TLR8 Q9NR97 2/20 0.34
▸ ATM Q13315 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17437439 0.84 RPS6KA5 (0.45) RPS6KA5POLBDYRK1ARPS6KB1CDK2
SCHEMBL17437495 0.84 HTR3A (0.41) RPS6KA5POLBKDM4ELMNAMAPT
SCHEMBL17437408 0.82 RPS6KA5 (0.41) RPS6KA5POLBDYRK1ARPS6KB1CDK2
SCHEMBL17437535 0.81 BRD4 (0.43) RPS6KA5POLBKDM4EALDH1A1LMNA
SCHEMBL17437314 0.78 TLR8 (0.34) RPS6KA5POLBTLR8
SCHEMBL16054029 0.77 ADORA2A (0.32) RPS6KA5POLB
SCHEMBL16054180 0.77 RPS6KA5 (0.41) RPS6KA5POLB
SCHEMBL17437525 0.76 ADORA2A (0.32) RPS6KA5POLB
SCHEMBL17437517 0.76 RPS6KA5 (0.37) RPS6KA5DYRK1ARPS6KB1CDK2ROCK1
SCHEMBL17437519 0.76 RPS6KA5 (0.37) RPS6KA5DYRK1ARPS6KB1CDK2ROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170050963-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2017-02-23 — — US disclosed
US-9512120-B2 Microbicidally active imidazopyridine derivatives SYNGENTA PARTICIPATIONS AG (CH) 2016-12-06 — — US disclosed
US-20160016949-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2016-01-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170050963-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES IDO1, IDO2, FOXM1 RPS6KA5 2731/4885POLB 1804/4885DYRK1A 1399/4885
US-20160016949-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES IDO1, IDO2, FOXM1 RPS6KA5 2731/4885POLB 1804/4885DYRK1A 1399/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback